Global health, biotechnological innovation and risk(s)

• Autor(a) principal: da Silva Figueiredo, Eduardo António
• Data de Publicação: 2020
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Cadernos Ibero-Americanos de Direito Sanitário (Online)
• Texto Completo: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/600
• topic: Global health. Right to health. Biotechnology. Risk. Precaution.; Salud Global. Derecho a la Salud. Biotecnología. Riesgo. Precaución.; Saúde global. Direito à Saúde. Biotecnologia. Risco. Precaução.

Objective: to reflect on the concept of global health, its origins, meaning(s) and main characteristics. To understand to what extent the doctrine has been referring to a Global Health Law, analyzing its main merits, limitations and inconveniences. To examine some of the biotechnological advances that have opened the doors to the possibility of increasing health and well-being on a global scale. Methodology: the deductive method was used from the analysis of monographies, articles from specialized reviews, as well as documents originating from several national and international entities. Results: in the context of a techno-scientific crisis, biotechnological innovation, although contributing to the improvement of global health, carries numerous risks. Increasingly, the importance of the so-called Global Health Law has been affirmed; it seeks to contribute to the optimization of health indices on a global scale, especially through the development of adequate precautionary responses. Conclusion: the improvement of health indices on a global scale depends, inter alia, on biotechnological innovation, which will only be made possible through an adequate risk management to be carried out on the concept of due diligence. The Global Health Law, understood as an international branch of Health Law, can make valuable contributions in this regard, despite its multiple limitations and difficulties.